TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: First-line clinical benefit rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean total point score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative biochemical failure probability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CTCAE grade≥2 toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: sCD62L levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SPARC levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of new ischemic brain lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: number of new ischemic brain lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: size of new ischemic brain lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: symptom improvement based on 4CS and SNOT-22
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rescue treatment use
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: radiographic ethmoid opacification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of symptoms assessed by the Blazina scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Impact on quality of life (QoL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: total airway volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ASES and Constant score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: DAS28-ESR improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PASI ≤ 3
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: DLQI 0/1
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Improvement of circadian blood pressure profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: decreased resting-state functional connectivity (rsFC) of the right hippocampus and right middle temporal gyrus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Voice Handicap Index (VHI-10)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acoustic Voice Index (AVI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: safety behaviors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of all stroke
Endpoint domain: Mortality/survival
Primary endpoint: expression of TMEM16A
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Face rating scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NRS for turn over
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cough NRS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction with the simulation experience
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean score of the CPR checklist after simulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility of administering 131I‐MIBG
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tolerability of administering 131I‐MIBG
Endpoint domain: Adverse events/effects
Primary endpoint: number of intrusive memories during week 5
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Need for further health-care contact
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Difference in pretest and post-test mean scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Readmission rate due to heart failure
Endpoint domain: Mortality/survival
Primary endpoint: Diagnosis time of VT/VE events
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma NfL levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Neutrophil-to-Lymphocyte Ratio (NLR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete remission rate (CCR)
Endpoint domain: Mortality/survival
Primary endpoint: time to shock reversal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage change in ghrelin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: cumulative HGAIN recurrence rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Chair Sit‐to‐Stand Test (CSTS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time until painless full weight bearing (FWB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean time-to-taste saccharin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1-year incidence of uterine leiomyoma
Endpoint domain: Mortality/survival
Primary endpoint: CKAQ SF scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: post‐test CKAQ scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Overall time to successful guidewire insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: 5-year CILP
Endpoint domain: Mortality/survival
Primary endpoint: 5-year EFS
Endpoint domain: Mortality/survival
Primary endpoint: change of mean PPD after 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: student absenteeism
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Reduction in the risk of NMOSD attacks
Endpoint domain: Mortality/survival
Primary endpoint: Walking distance (6MWD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical component of quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: percent muscle activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Estimated intubation depth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with GIM detected
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic yield for GIM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of extensive GIM detected
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Deterioration of glaucomatous visual field loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in autonomic–anxiety subscore of VSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HADS anxiety score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HMax:MMax ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: peak knee and hip angles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: range of motion in hip and knee
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: iDFS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Transmission of HIV
Endpoint domain: Mortality/survival
Primary endpoint: anxiety levels on operation day
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Hemoglobin Level (HBL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Maximum Hemoglobin Drop
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: EQ-5D-5L utilities
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Understanding of anatomy
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Visualization of pathology
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Understanding of surgical approach
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: BLa-
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Freedom from Disease Progression (FFDBM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: micro-precision
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: micro-recall
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: micro-F1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean EQ-5D-5L visual analogue scale (VAS)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: mean utility score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: problems in HRQoL domains
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Percentage of days alive without life support
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: plasma levels of lipid hydroperoxides
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: plasma levels of conjugated dienes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: plasma levels of malondialdehyde
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: 50% or greater reduction in mean MMDs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fluid overload
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: renal biomarkers (NGAL and KIM-1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Cannulation time using POCUS guidance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: AUC for differentiating between benign and malignant SPGGNs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity (recall score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain on rising from a chair
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean cup anteversion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in risk literacy (QRT scores)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in statistics anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Use of DCO vs. DC in patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: increased water consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resistance to at least two drugs of current regimen
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Hospitalisation for ADHF at 90 days
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: 1-year TLF rates
Endpoint domain: Mortality/survival
Primary endpoint: Endotracheal intubation (ETI) rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Days free from respiratory support
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Length of RICU stay
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Risk of Alzheimer's disease
Endpoint domain: Mortality/survival
Primary endpoint: Interpersonal Challenges (IC) during treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient worry during therapy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Creatinine concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 35 m sprint results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of exclusive breastfeeding (EBF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: thirst discomfort
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in clinical decision-making scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in turbinate size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nasal complaints
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Success rate of relocations based on 2D-2D resetting
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average duration of intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Average volume of contrast (VC) injected
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: EORTC global health score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: EORTC symptom scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Proportion of insomnia remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Excellent bowel preparation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Palatability of solution
Endpoint domain: Adverse events/effects
Primary endpoint: AF and/or atrial flutter induction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of corneal infiltrative events (CIEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of grade 3 to 4 hematologic toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: D-12
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: MCLC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: FACIT-F
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Reduction in MS and LB levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: word reading reaction times (RTs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: neural activity changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Conduction velocity of peroneal nerve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Subjective satisfaction with pronunciation ability
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Decline of ACE‐2AT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Improvement of ISIClamp
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Total serum antioxidant capacity (TAC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to emergence/extubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to respiratory recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: duration of PACU stay
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nerve tension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: nocturnal PtcCO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Assessment of Physiotherapy Practice scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Colectomy-free survival
Endpoint domain: Mortality/survival
Primary endpoint: incidence of moderate-to-severe NPSAEs
Endpoint domain: Adverse events/effects
Primary endpoint: odds of light-headedness
Endpoint domain: Adverse events/effects
Primary endpoint: odds of post-dialysis hypervolemia
Endpoint domain: Adverse events/effects
Primary endpoint: Expression of miR-182
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cases of osteopenia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Bone and lymphatic system outcomes
Primary endpoint: cognitive skills
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: motor cortical excitability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: DRSE (Drinking Refusal Self-Efficacy)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: postoperative blood glucose levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: postoperative mean thirst scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of end of life (care) as measured with the QOD‐LTC
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Length of hospitalizations
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: weekly rate of traditional referrals
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: weekly rate of eConsults
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: PCP satisfaction with eConsult program
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Successful vaginal birth after cesarean (VBAC)
Endpoint domain: Mortality/survival
Primary endpoint: REVEAL Lite 2 score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stabilization or improvement in risk stratum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Achieving low-risk status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to initiation of chemotherapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improved behaviours in greeting the caller
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improved behaviours in acknowledging the caller
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improved behaviours in displaying empathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Faster logging of first decisions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Colonization with AmpC‐producing enterobacteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Infection with ESBL‐producing bacteria
Endpoint domain: Adverse events/effects
Primary endpoint: Expression of estrogen receptor (ER)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Expression of progesterone receptor (PR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: first myocardial infarction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: clinical and radiological scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recovery rate by day 30
Endpoint domain: Mortality/survival
Primary endpoint: Hospitalization status
Endpoint domain: Mortality/survival
Primary endpoint: Maximum bite forces
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Final evaluation scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical IPV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in EASI score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ACR50/ACR70 improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Jaw Functional Limitation Scale 20 (JFLS‐20)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in ischemia over 1 year
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Improvement in angina
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: poor mRS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in generalized anxiety symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improvement in cardiac recovery indexes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: mean implant stability quotient (ISQ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Drug-related grade ≥ 3 adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Efficacy against RSV‐MS‐LRTI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of RSV‐LRTI with severe hypoxemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of pneumonia as a serious adverse event
Endpoint domain: Adverse events/effects
Primary endpoint: COVID-19 vaccine acceptance and uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self‐reported changes in daily life
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of vaginal delivery <24 h
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Time to induction delivery (TID)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes